-
COMPARATIVE EFFECTIVENESS OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING METHODS VERSUS TRADITIONAL DISPROPORTIONALITY ANALYSIS FOR ADVERSE DRUG REACTION SIGNAL DETECTION: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
GEOGRAPHIC AND TEMPORAL TRENDS IN ADULT DIABETES PREVALENCE, UNITED STATES, 2011-2021
Mar 18, 2026, 21:38 PM -
ASSOCIATIONS BETWEEN SOCIAL DETERMINANTS OF HEALTH AND OUTCOMES AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Mar 18, 2026, 21:38 PM -
INTEGRATION OF GENERATIVE ARTIFICIAL INTELLIGENCE INTO THE DEVELOPMENT OF STATISTICAL ANALYSIS PLANS FOR PATIENT-REPORTED OUTCOMES
Mar 18, 2026, 21:38 PM -
DIAGNOSTIC YIELD OF SHAPE-SENSING ROBOTIC-ASSISTED BRONCHOSCOPY: AN UPDATED META-ANALYSIS
Mar 18, 2026, 21:38 PM -
PSYCHOSOCIAL CORRELATES OF HEALTH ANXIETY IN A HEALTHY ADULT POPULATION
Mar 18, 2026, 21:38 PM -
UNDERSTANDING PERSPECTIVES, BARRIERS AND ENABLERS FOR CLINICAL TRIAL PARTICIPATION IN REPRESENTATIVE PATIENT POPULATIONS
Mar 18, 2026, 21:38 PM -
EVALUATING THE PERFORMANCE OF A GENERATIVE ARTIFICIAL INTELLIGENCE CHATBOT FOR ASSESSING SYSTEMATIC LITERATURE REVIEWS USING THE PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES 2020 CHECKLIST
Mar 18, 2026, 21:38 PM -
EVALUATION OF PSYCHOMETRIC PROPERTIES OF THE PHENYLKETONURIA-SYMPTOM SEVERITY AND IMPACTS SCALE (PKU-SSIS) IN ADOLESCENTS WITH PKU
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF SACITUZUMAB GOVITECAN AMONG METASTATIC TRIPLE-NEGATIVE BREAST CANCER PATIENTS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
A COMPARATIVE ASSESSMENT OF TRAVEL BURDEN AND PRODUCTIVITY LOSS FOR CAR T-CELL THERAPY AND BISPECIFIC ANTIBODY TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY LBCL USING US CLAIMS DATA
Mar 18, 2026, 21:38 PM -
MEDICATION-TAKING BEHAVIOUR IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD): A QUALITATIVE ANALYSIS OF SOCIAL MEDIA DATA
Mar 18, 2026, 21:38 PM -
REAL-WORLD CLINICAL OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN CHINESE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
WHO IS MOST AT RISK OF UNRECOGNIZED DIABETES? A STUDY TO INFORM PHARMACIST ACTION
Mar 18, 2026, 21:38 PM -
ASSESSING UNMET THERAPEUTIC NEED IN MEDICAID PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) AND TYPE 2 DIABETES
Mar 18, 2026, 21:38 PM -
ARE MEDICARE’S NEGOTIATED PRICES FOR APIXABAN AND RIVAROXABAN CONSISTENT WITH VALUE BASED PRICES? EVIDENCE FROM A SYSTEMATIC REVIEW OF U.S. COST-EFFECTIVENESS ANALYSES
Mar 18, 2026, 21:38 PM -
PATIENT-CENTRIC PATHWAYS: SURVEYING TREATMENT ACCESS AND SUPPORT FOR RARE DISEASES, INCLUDING RARE CANCERS, IN EUROPE
Mar 18, 2026, 21:38 PM -
ECONOMIC AND CLINICAL OUTCOMES OF CELL-BASED VERSUS EGG-BASED INFLUENZA VACCINES IN U.S. PEDIATRIC AND ADULT POPULATIONS: A MODELING STUDY
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT ANALYSIS OF RITLECTINIB FOR TREATMENT OF ALOPECIA AREATA IN A TERTIARY GOVERNMENT HOSPITAL IN RIYADH
Mar 18, 2026, 21:38 PM -
REAL-WORLD EVIDENCE METHODOLOGY FOR ECONOMIC EVALUATION OF CLINICAL AI: COST-EFFECTIVENESS OF AN IMAGING ALGORITHM FOR INCIDENTAL DETECTION OF EMPHYSEMA
Mar 18, 2026, 21:38 PM
